Accelerating Australian HealthTech Innovation: LuminaX 2026 Cohort Announced

5 minute read

Now in its sixth year, the LuminaX HealthTech Accelerator Program has officially kicked off, welcoming a new cohort of 10 Australian startups into its 14‑week, in‑person accelerator based within the Gold Coast Health & Knowledge Precinct.

Delivered by LX Health and backed by Economic Development Queensland (EDQ), LuminaX is designed to help early‑stage healthtech founders validate, commercialise and scale solutions addressing some of healthcare’s most pressing challenges.

Following a highly competitive national selection process, the 2026 cohort represents some of Australia’s most promising emerging health, medtech, biotech and sportstech innovators. Collectively, these startups reflect a strong shift towards preventative, personalised and proactive healthcare, with solutions focused on early detection, long‑term monitoring and empowering individuals to take control of their health and wellbeing before illness develops.

LX Health Program Director Dren Xerxa said the 2026 intake highlights both the maturity and momentum of the Australian healthtech ecosystem.

“What stands out is the number of founders building solutions that work upstream — focusing on prevention, early detection and personalised monitoring. This is where the biggest opportunity lies, and it’s exciting to see Australian founders leading innovation in this space,” Xerxa said.

A proven pathway from innovation to impact

Since launching in 2021, LuminaX has grown into one of Australia’s leading healthtech accelerators. Over the past five years, 52 Australian healthtech startups have completed the program, collectively raising more than $33 million in funding and connecting with over 1,000 clinicians, executives and industry leaders.

Notably, half of the successful applicants in the 2026 cohort are female‑led, reflecting the program’s ongoing commitment to founder diversity and inclusive innovation across the healthtech sector.

Participants benefit from hands‑on mentorship, clinical access, investor connections and expert guidance across health, technology and capital — supporting founders to sharpen their solutions and accelerate commercial success.

LuminaX is delivered within Lumina Gold Coast, a 9.5‑hectare, purpose‑built innovation community located in the heart of the Gold Coast Health & Knowledge Precinct. Designed to support health, technology and innovation‑driven enterprises, Lumina Gold Coast provides a unique environment where researchers, clinicians and industry partners collide.

Strengthening Queensland’s health innovation ecosystem

LuminaX plays a critical role in building Queensland’s health and knowledge economy by nurturing high‑growth startups, attracting talent and investment, and accelerating pathways from innovation to real‑world impact.

As a flagship program within the Gold Coast Health & Knowledge Precinct, LuminaX contributes to:

• Building a globally competitive innovation precinct by attracting ambitious founders, industry partners and capital
• Supporting commercialisation and job creation in one of Australia’s fastest‑growing sectors
• Improving health outcomes through solutions that reduce system pressure, improve access to care and deliver better outcomes for communities

The program is delivered in partnership with the Queensland Government through Economic Development Queensland, alongside Invest Gold Coast and QIC as major partners. Industry partners include Griffith University, Gold Coast Hospital and Health Service, the National Rugby League (NRL) and Gold Coast Health & Knowledge Precinct, ensuring founders have access to world‑class expertise, infrastructure and real‑world clinical environments.

The LuminaX 2026 participants

The 2026 LuminaX cohort brings together diverse founders and technologies with the potential to reshape healthcare delivery in Australia and beyond:

• Ketim Technologies — Developing the world’s first predictive blood test for postpartum depression, combining multi‑protein biomarkers and AI to identify at‑risk mothers during pregnancy, before symptoms begin.
• CARED — An Australia‑wide allied health and care platform that matches people to the right clinicians and carers, delivering services supported by strong clinical governance and a seamless digital experience.
• Exonova Biotech — Revolutionising endometriosis diagnosis to help women access faster, more accurate answers to one of healthcare’s most under‑diagnosed conditions.
• Gild — Rebuilding healthcare payments infrastructure to enable compliant gap‑only payments and automated Medicare rebate routing, reducing upfront costs for patients while ensuring clinics are paid accurately and on time.
• Hormone Tracking System — A daily at‑home hormone tracking device that helps predict energy levels and guide life, wellness and training decisions, putting hormonal health intelligence directly into people’s hands.
• Mind Maze — Building preventative behavioural health infrastructure in primary schools through engaging, gamified learning that equips children with tools to support their mental wellbeing from an early age.
• MyoIntel — Creating athlete‑specific digital twins that turn commonly used team‑sport data into muscle‑level workload insights for performance and injury management.
• Nouscope — A governed AI reasoning platform that makes clinical AI deployable by ensuring every output is traceable to evidence, auditable and defensible within regulated healthcare workflows.
• Sonorus — An impact‑driven healthcare company building an AI‑powered medical device to non‑invasively screen for rheumatic heart disease, with a focus on reaching communities where access to diagnosis has historically been limited.
• Tolaris Labs – Patient-specific surgical digital twins for vascular intervention, procedural planning, and device-risk insight.

Looking ahead

The LuminaX 2026 cohort reflects the depth, ambition and diversity of Australia’s emerging healthtech sector. Over the coming 14 weeks, founders will work alongside mentors, clinicians, investors and industry partners to refine their solutions, strengthen commercial foundations and prepare for growth.

As LuminaX enters its next chapter, it continues to play a vital role in turning bold healthtech ideas into scalable businesses — supporting better health outcomes, stronger industries and long‑term impact for Queensland and Australia.